Oderda, M.; Dematteis, A.; Calleris, G.; Conti, A.; D’Agate, D.; Falcone, M.; Marquis, A.; Montefusco, G.; Marra, G.; Gontero, P.
Predictors of Prostate Cancer at Fusion Biopsy: The Role of Positive Family History, Hypertension, Diabetes, and Body Mass Index. Curr. Oncol. 2023, 30, 4957-4965.
https://doi.org/10.3390/curroncol30050374
AMA Style
Oderda M, Dematteis A, Calleris G, Conti A, D’Agate D, Falcone M, Marquis A, Montefusco G, Marra G, Gontero P.
Predictors of Prostate Cancer at Fusion Biopsy: The Role of Positive Family History, Hypertension, Diabetes, and Body Mass Index. Current Oncology. 2023; 30(5):4957-4965.
https://doi.org/10.3390/curroncol30050374
Chicago/Turabian Style
Oderda, Marco, Alessandro Dematteis, Giorgio Calleris, Adriana Conti, Daniele D’Agate, Marco Falcone, Alessandro Marquis, Gabriele Montefusco, Giancarlo Marra, and Paolo Gontero.
2023. "Predictors of Prostate Cancer at Fusion Biopsy: The Role of Positive Family History, Hypertension, Diabetes, and Body Mass Index" Current Oncology 30, no. 5: 4957-4965.
https://doi.org/10.3390/curroncol30050374
APA Style
Oderda, M., Dematteis, A., Calleris, G., Conti, A., D’Agate, D., Falcone, M., Marquis, A., Montefusco, G., Marra, G., & Gontero, P.
(2023). Predictors of Prostate Cancer at Fusion Biopsy: The Role of Positive Family History, Hypertension, Diabetes, and Body Mass Index. Current Oncology, 30(5), 4957-4965.
https://doi.org/10.3390/curroncol30050374
